1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma

Clinica Chimica Acta

Volumn 401, Issue 1-2, 2009, Pages 8-13

  Zhou, Jinglin ^a   Xu, Bin ^a   Huang, Jing ^b   Jia, Xiangming ^b   Xue, Jing ^a   Shi, Xinchang ^a   Xiao, Liying ^a   Li, Wei ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

1H NMR spectroscopy; Metabonomics; OSCC; PCA; PLS DA

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOPLAKIA; MALE; MOUTH CARCINOMA; PATTERN RECOGNITION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SQUAMOUS CELL CARCINOMA; BLOOD; DISCRIMINANT ANALYSIS; EVALUATION; METABOLOMICS; METHODOLOGY; MIDDLE AGED; MOUTH TUMOR; NUCLEAR MAGNETIC RESONANCE; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; REGRESSION ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; LEUKOPLAKIA, ORAL; MALE; METABOLOMICS; MIDDLE AGED; MOUTH NEOPLASMS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PRINCIPAL COMPONENT ANALYSIS;

EID: 58549085747     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.10.030     Document Type: Article

References (45)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics. CA Cancer J Clin 51 (2001) 15-36
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
3. Rodriguez T., Altieri A., Chatenoud L., et al. Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol 40 2 (2004) 207-213
4. Moore S.R., Johnson N.W., Pierce A.M., and Wilson D.F. The epidemiology of mouth cancer: a review of global incidence. Oral Dis 6 (2000) 65-74
5. Lopez M., Aguirre J.M., Cuevas N., Anzola M., et al. Gene promoter hypermethylation in oral rinses of leukoplakia patients - a diagnostic and/or prognostic tool?. Eur J Cancer 39 (2003) 2306-2309
6. Bloor B.K., Seddon S.V., and Morgan P.R. Gene expression of differentiation-specific keratins in oral epithelial dysplasia and squamous cell carcinoma. Oral Oncol 37 (2001) 251-261
7. Scheifele C., and Reichart P. Is there a natural limit of the transformation rate of oral leukoplakia?. Oral Oncol 39 (2003) 470-475
8. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 14 (2003) 47-62
9. Bristow R.G., and Hill R.P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8 3 (2008) 180-192
10. Weinmann M., Belka C., and Plasswilm L. Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours. Onkologie 27 (2004) 83-90
11. Raju B., Haug S.R., Ibrahim S.O., and Heyeraas K.J. High interstitial fluid pressure in rat tongue cancer is related to increased lymph vessel area, tumor size, invasiveness and decreased body weight. J Oral Pathol & Med 37 3 (2008) 137-144
12. Milosevic M., Fyles A., and Hill R. Interstitial fluid pressure in cervical cancer: guide to targeted therapy. Am J Clin Oncol 24 5 (2001) 516-521
13. 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. Cancer Res. 61 17 (2001) 6524-6531
14. Nicholson J.K., and Wilson I.D. High resolution proton magnetic resonance spectroscopy of biological fluids. Prog NMR Spectrosc 21 (1989) 449-501
15. Manoharana S., Padmanabhana M., Kolanjiappana K., Ramachandranb C.R., et al. Analysis of glycoconjugates in patients with oral squamous cell carcinoma. Clin Chim Acta 339 (2004) 91-96
16. Kim C.H., Lee J.S., Kang S.O., Bae J.H., Hong S.P., and Hison K. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma. Oral Oncol 43 (2007) 1021-1025
17. Saussez S., Lorfevre F., Lequeux T., Laurent G., et al. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy. Oral Oncol 44 1 (2008) 86-93
18. Huang X., Wei Y.Q., Li L.J., et al. Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. Oral Oncol 42 (2006) 26-31
19. Gokhale A.S., Haddad R.I., Cavacini L.A., et al. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck. Oral Oncol 41 1 (2005) 70-76
20. 1H NMR metabonomics to breast cancer characterization and detection. Prog Nucl Magn Reson Spectrosc 47 (2005) 165-174
21. 1H NMR-based metabonomics. Int. J. Cancer 113 (2005) 782-788
22. Oliver P., Whelehan M.E., Earll E.J., et al. Detection of ovarian cancer using chemometric analysis of proteomic profiles. Chemometr Intell Lab Syst 84 (2006) 82-87
23. Lindon J.C., Holmes E., and Nicholson J.K. So what's the deal with metabonomics?. Anal Chem 75 17 (2003) 385A-391A
24. Griffin J.L., and Shockcor J.P. Metabolic profiles of cancer cells. Nat Rev Cancer 4 (2004) 551-561
25. Nicholson J.K., Lindon J.C., and Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR data. Xenobiotica 29 (1999) 1181-1189
26. Jurs P.C. Pattern recognition used to investigate multivariate data in analytical chemistry. Science 232 (1986) 1219-1224
27. Eriksson L., Johansson E., Kettanah-Wold N., et al. Introduction to multi and megavariate data analysis using projection methods, PCA and PLS. UMETRICS (1999)
28. Bobby L., Boyanton, and Blick K.E. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 48 (2002) 2242-2247
29. Lucas L.H., Larive C.K., Wilkinson P.S., and Huhn S. Progress toward automated metabolic profiling of human serum: comparison of CPMG and gradient-filtered NMR analytical methods. J Pharm Biomed Anal 39 (2005) 156-163
30. Tang H., Wang Y.L., Nicholson J.K., and Lindon J.C. Use of relaxation-edited one-dimensional and two-dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal Biochem 325 (2004) 260-272
31. 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed 11 (1998) 235-244
32. Holmes E., Nicholls A.W., and Lindon J.C. Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem Res Toxicol 13 (2000) 471-478
33. Lindon J.C., Holmes E., and Nicholson J.K. Pattern recognition methods and applications in biomedical magnetic resonance. Prog Nucl Magn Reson Spectrosc 39 (2001) 1-40
34. Jackson J.E. A User's Guide to Principal Components (1991), Wiley, New York
35. Eriksson L., Johansson E., Kettaneh-Wold H., and Wold S. Introduction to multi and megavariate analysis using projection methods (PCA and PLS). UMETRICS Inc., Umeå (1999)
36. Karp N.A., Griffin J.L., and Lilley K.S. Application of partial least squares discriminant analysis to two-dimensional difference gel studies in expression proteomics. Proteomics 5 (2005) 81-90
37. Gavaghana C.L., Wilsonb I.D., and Nicholsona J.K. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett 530 (2002) 191-196
38. Whelehan O.P., Earll M.E., Johansson E., Toft M., and Lennart E. Detection of ovarian cancer using chemometric analysis of proteomic profiles. Chemometr Intell Lab Syst 84 (2006) 82-87
39. 1H NMR spectroscopy of human blood plasma. Prog Nucl Magn Reson Spectrosc 27 (1995) 475-554
40. 1H NMR-based metabonomic study of urine from healthy human subjects. J Pharm Biomed Anal 33 (2003) 1103-1115
41. Psihogios N.G., Gazi I.F., Elisaf M.S., Seferiadis K.I., and Bairaktari E.T. Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed 21 3 (2008) 195-207
42. 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. Anal Biochem 220 2 (1994) 284-296
43. 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed 11 4-5 (1998) 235-244
44. Holmes E., and Antti H. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. Analyst 127 (2002) 1549-1557
45. Keun H.C., Ebbels T.M.D., Antti H., et al. Improved analysis of multivariate data by variable stability scaling: application to NMR-based metabolic profiling. Anal Chim Acta 490 (2003) 265-276